On 2025-05-14, Aardvark Therapeutics, Inc. (AARD) announced earnings per share of $-0.71 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.70.

The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.59 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.